Close
Back to MRNS Stock Lookup

Marinus Pharma (MRNS) – Litigation

Mar 27, 2024 08:41 AM Marinus Pharma (MRNS) Comments on Patent Challenge by Ovid, Provides Update on Marinus’ Post Grant Review
Jun 21, 2023 04:01 PM Marinus Pharma (MRNS) Announces New Method of Use Patent Granted for IV Ganaxolone by USPTO in Status Epilepticus

Back to MRNS Stock Lookup